abanoquil has been researched along with enalaprilat anhydrous in 1 studies
Studies (abanoquil) | Trials (abanoquil) | Recent Studies (post-2010) (abanoquil) | Studies (enalaprilat anhydrous) | Trials (enalaprilat anhydrous) | Recent Studies (post-2010) (enalaprilat anhydrous) |
---|---|---|---|---|---|
22 | 5 | 0 | 846 | 109 | 76 |
Protein | Taxonomy | abanoquil (IC50) | enalaprilat anhydrous (IC50) |
---|---|---|---|
Angiotensin-converting enzyme | Mus musculus (house mouse) | 0.0115 | |
Angiotensin-converting enzyme | Homo sapiens (human) | 0.2405 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.0054 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0012 | |
Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.0036 | |
Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.0024 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
1 other study(ies) available for abanoquil and enalaprilat anhydrous
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |